Sara Martin
Pulmonary Disease · Mountain Home, ARNPI 1861616021
Payments from drug & device makers
Across 156 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$527
- Boehringer Ingelheim$312
- AstraZeneca$304
- Grifols USA, LLC$195
- Mallinckrodt Hospital Products Inc.$148
- Takeda Pharmaceuticals U.S.A., Inc.$143
- plus $692 from 19 others
What the payments were for
- Food & beverage$2,320100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 46 | $527 |
| Boehringer Ingelheim | 20 | $312 |
| AstraZeneca(2 entities) | 22 | $304 |
| Grifols USA, LLC | 11 | $195 |
| Mallinckrodt Hospital Products Inc. | 8 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $143 |
| Mylan Specialty L.p. | 7 | $107 |
| Actelion Pharmaceuticals US, Inc. | 5 | $83 |
| Baxter Healthcare | 3 | $60 |
| Sanofi | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Advanced Respiratory, Inc | 4 | $45 |
| Boston Scientific | 1 | $38 |
| Mallinckrodt Enterprises LLC | 2 | $32 |
| Vifor Pharma, Inc. | 2 | $29 |
| Chiesi USA, Inc. | 2 | $25 |
| Bayer | 2 | $23 |
| Pulmonx Corporation | 1 | $23 |
| United Therapeutics Corporation | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Merck | 1 | $17 |
| Gilead | 1 | $17 |
| Pfizer | 1 | $16 |
| Philips North America LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$2,320 in reported general payments places this provider in the 35th percentile of 102 pulmonary disease providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 146 | $121,611 |
| Breo ElliptaFluticasone/Vilanterol | 61 | $29,216 |
| Spiriva RespimatTiotropium Bromide | 42 | $28,308 |
| SymbicortBudesonide/Formoterol Fumarate | 65 | $19,872 |
| Advair HfaFluticasone Propion/Salmeterol | 16 | $11,445 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 151 | $5,801 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,153 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $4,446 |
| Ventolin HfaAlbuterol Sulfate | 38 | $2,945 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,197 |
| Azithromycin | 111 | $1,142 |
| Montelukast Sodium | 107 | $655 |
| Prednisone | 38 | $189 |
| Fluticasone Propionate | 18 | $140 |
| Omeprazole | 16 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $527 | $155,980218 claims |
| Boehringer IngelheimSpiriva Respimat | $312 | $28,30842 claims |
| AstraZenecaSymbicort | $304 | $19,87265 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 102 pulmonary disease providers in Arkansas.
Other pulmonary disease in Mountain Home
- Brian MalteMountain Home$14K
- Larry JohnsonLittle Rock$847K
- Timothy CookSherwood$638K
- Nikhil MeenaLittle Rock$574K
- Raghu ReddyLittle Rock$541K
- Ladly AbrahamConway$521K
- Daniel PaulRogers$244K
- Jason McKinneyRogers$86K
- Arturo MeadeFort Smith$67K
- Rajani JaganaLittle Rock$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.